Claudio Papi
Claudio Papi
UOS Malattie infiammatorie croniche dell'intestino, UOC Gastroenterologia Osp. S Filippo Neri, Roma
Email verificata su
TitoloCitata daAnno
Hepatitis B virus replication
J Beck, M Nassal
World journal of gastroenterology: WJG 13 (1), 48, 2007
Evidence-based appraisal of antireflux fundoplication
M Catarci, P Gentileschi, C Papi, A Carrara, R Marrese, AL Gaspari, ...
Annals of surgery 239 (3), 325, 2004
Timing of cholecystectomy for acute calculous cholecystitis: a meta-analysis
C Papi, M Catarci, L D'ambrosio, L Gili, M Koch, GB Grassi, L Capurso
The American journal of gastroenterology 99 (1), 147, 2004
Advanced age is an independent risk factor for severe infections and mortality in patients given anti–tumor necrosis factor therapy for inflammatory bowel disease
M Cottone, A Kohn, M Daperno, A Armuzzi, L Guidi, R D'Inca, F Bossa, ...
Clinical Gastroenterology and Hepatology 9 (1), 30-35, 2011
Risk of inflammatory bowel disease attributable to smoking, oral contraception and breastfeeding in Italy: a nationwide case-control study
G Corrao, A Tragnone, R Caprilli, G Trallori, C Papi, A Andreoi, ...
International journal of epidemiology 27 (3), 397-404, 1998
Efficacy of rifaximin in the treatment of symptomatic diverticular disease of the colon. A multicentre double‐blind placebo‐controlled trial
C Papi, A Ciaco, M Koch, L Capurso
Alimentary pharmacology & therapeutics 9 (1), 33-39, 1995
Infliximab and newly diagnosed neoplasia in Crohn’s disease: a multicentre matched pair study
L Biancone, A Orlando, A Kohn, E Colombo, R Sostegni, E Angelucci, ...
Gut 55 (2), 228-233, 2006
Colectomy rate in acute severe ulcerative colitis in the infliximab era
A Aratari, C Papi, V Clemente, A Moretti, R Luchetti, M Koch, L Capurso, ...
Digestive and Liver Disease 40 (10), 821-826, 2008
Budesonide in the treatment of Crohn’s disease: a meta‐analysis
C Papi, R Luchetti, L Gili, S Montanti, M Koch, L Capurso
Alimentary pharmacology & therapeutics 14 (11), 1419-1428, 2000
The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: the use of tumor…
A Orlando, A Armuzzi, C Papi, V Annese, S Ardizzone, L Biancone, ...
Digestive and Liver Disease 43 (1), 1-20, 2011
Is early endoscopic retrograde cholangiopancreatography useful in the management of acute biliary pancreatitis?: A meta-analysis of randomized controlled trials
A Moretti, C Papi, A Aratari, V Festa, M Tanga, M Koch, L Capurso
Digestive and liver disease 40 (5), 379-385, 2008
Meta‐analysis: long‐term therapy with rifaximin in the management of uncomplicated diverticular disease
M Bianchi, V Festa, A Moretti, A Ciaco, M Mangone, V Tornatore, A Dezi, ...
Alimentary pharmacology & therapeutics 33 (8), 902-910, 2011
Two mesalazine regimens in the prevention of the post‐operative recurrence of Crohn's disease: a pragmatic, double‐blind, randomized controlled trial
R Caprilli, M Cottone, F Tonelli, GC Sturniolo, F Castiglione, V Annese, ...
Alimentary pharmacology & therapeutics 17 (4), 517-523, 2003
Crucial steps in the natural history of inflammatory bowel disease
G Latella, C Papi
World journal of gastroenterology: WJG 18 (29), 3790, 2012
Early versus late surgery for ileo‐caecal Crohn’s disease
A Aratari, C Papi, G Leandro, A Viscido, L Capurso, R Caprilli
Alimentary pharmacology & therapeutics 26 (10), 1303-1312, 2007
Infliximab in the treatment of Crohn's disease: predictors of response in an Italian multicentric open study
A Orlando, E Colombo, A Kohn, L Biancone, F Rizzello, A Viscido, ...
Digestive and liver disease 37 (8), 577-583, 2005
Infliximab in refractory pouchitis complicated by fistulae following ileo‐anal pouch for ulcerative colitis
A Viscido, FI Habib, A Kohn, C Papi, A Marcheggiano, MT Pimpo, ...
Alimentary pharmacology & therapeutics 17 (10), 1263-1271, 2003
Age-related clinical severity at diagnosis in 1705 patients with ulcerative colitis
G Riegler, MT Tartaglione, R Carratu, R D'inc, D Valpiani, MI Russo, ...
Digestive diseases and sciences 45 (3), 462-465, 2000
Efficacy of rifaximin on symptoms of uncomplicated diverticular disease of the colon. A pilot multicentre open trial. Diverticular Disease Study Group.
C Papi, A Ciaco, M Koch, L Capurso
The Italian journal of gastroenterology 24 (8), 452-456, 1992
Hepatobiliary alterations in patients with inflammatory bowel disease: a multicenter study
G Riegler, R D'INC, GC Sturniolo, G Corrao, CDV Blanco, V Di Leo, ...
Scandinavian journal of gastroenterology 33 (1), 93-98, 1998
Il sistema al momento non pu eseguire l'operazione. Riprova pi tardi.
Articoli 1–20